Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022)

Prime Medicine's Preferred Dividend Payments history spans 2 years, with the latest figure at $1.3 million for Q4 2022.

  • For Q4 2022, Preferred Dividend Payments rose 113.9% year-over-year to $1.3 million; the TTM value through Sep 2023 reached $1.3 million, down 86.06%, while the annual FY2022 figure was $20.2 million, 1275.54% up from the prior year.
  • Preferred Dividend Payments reached $1.3 million in Q4 2022 per PRME's latest filing, down from $6.4 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $6.4 million in Q3 2022 to a low of -$9.5 million in Q4 2021.